Strokectomy in Malignant Cerebral Media Infarction

Recruiting N/A Interventional Study
Stroke, Ischemic
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
10 (estimated)
Sponsor
University of Rostock · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Decompressive hemicraniectomy (DC) is the standard procedure and life saving measure in case of malignant middle cerebral artery (MCA) infarction. However, there have been several studies reporting the neuroinflammatory cascade based on the necrotic tissue as one of the leading cause for the secondary brain damage, wherefore, strokectomy with resection of necrotic tissue has been proposed in some …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 18 years of age or older * Ischemic middle cerebral artery (MCA) infarction at least two thirds of the MCA territory * Clinical symptoms of acute unilateral MCA infarction less than 48 hours prior to the initiation of treatment Exclusion Criteria: * Preexisting modified Rank…
Contacts

Melanie Sparre

0381 494 6419

melanie.sparre@med.uni-rostock.de

CONTACT

Sae-Yeon Won, MD

0381 494 146067

sae-yeon.won@med.uni-rostock.de

CONTACT